NASDAQ:GCTK - Nasdaq - US45824Q6061 - Common Stock - Currency: USD
GLUCOTRACK INC
NASDAQ:GCTK (2/5/2025, 8:02:12 PM)
After market: 0.697 -0.01 (-1.69%)0.709
-0.1 (-12.47%)
The current stock price of GCTK is 0.709 USD. In the past month the price decreased by -77.77%. In the past year, price decreased by -96.92%.
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and...
The study met its primary endpoint with no procedure or device related serious adverse events reported
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.28 | 229.05B | ||
ISRG | INTUITIVE SURGICAL INC | 80.61 | 210.47B | ||
BSX | BOSTON SCIENTIFIC CORP | 44.48 | 154.71B | ||
SYK | STRYKER CORP | 32.74 | 152.14B | ||
MDT | MEDTRONIC PLC | 17.46 | 117.57B | ||
BDX | BECTON DICKINSON AND CO | 18.62 | 71.07B | ||
EW | EDWARDS LIFESCIENCES CORP | 27 | 42.52B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.66 | 39.83B | ||
IDXX | IDEXX LABORATORIES INC | 41.65 | 38.36B | ||
RMD | RESMED INC | 27.44 | 35.61B | ||
DXCM | DEXCOM INC | 52.22 | 34.68B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.62 | 25.78B |
GlucoTrack Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Rutherford, New Jersey and currently employs 6 full-time employees. The company went IPO on 2013-04-09. GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The firm is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. The company is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an approximately two-year implant longevity without the requirement for any wearable components. The CBGM utilizes an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood vessel. This facilitates continuous blood glucose measurements with zero lag time. The firm is also developing the Glucotrack CBGM a companion mobile application and a cloud-based solution to provide real time, data-driven personalized tools to effectively help a user manage their diabetes and assist healthcare providers with making treatment decisions.
GLUCOTRACK INC
301 Rt 17 North, Suite 800
Rutherford NEW JERSEY US
Employees: 6
Company Website: http://www.integrity-app.com/
Investor Relations: http://www.integrity-app.com/investor-relations/
Phone: 12018427715
The current stock price of GCTK is 0.709 USD.
The exchange symbol of GLUCOTRACK INC is GCTK and it is listed on the Nasdaq exchange.
GCTK stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for GCTK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of GCTK.
GCTK does not pay a dividend.
GCTK does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.85).
The outstanding short interest for GCTK is 10.93% of its float.
Over the last trailing twelve months GCTK reported a non-GAAP Earnings per Share(EPS) of -2.85. The EPS decreased by -80.32% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1805.69% | ||
ROE | N/A | ||
Debt/Equity | N/A |